Studies of the expression of CD40~+、CD40L~+ and CD8~+/CD28~+ on peripheral blood cells in patients with chronic B hepatitis
Qiu Lian
Abstract
Qiu Lian
Abstract
Objective:To test CD40~+、CD40L~+ and CD8~+/CD28~+、CD8~+/CD28~- on peripheral blood of chronic B hepatitis evaluate patients's celluar immunity and to guide clinical treatment.Methods:CD40~+、CD40L~+ and CD8~+/CD28~+、CD8~+/CD28~- expression on peripheral blood cells in chronic B hepatitis were detected by flow cytometry.Results:CD40~+、CD40L~+ and CD8~+/CD28~+ in chronic B hepatitis and liver cirrhosis patients were lower than in the health.CD8~+/CD28~- in chronic B hepatitis and liver cirrhosis patients were higher than in the health.But there were no remarkable difference between in chronic B hepatitis and in liver cirrhosis.Also there were no remarkable difference in mild、moderate、severve chronic B hepatitis and liver cirrhosis (P0.05).There was a positive corrlation on CD40~+ and CD40L~+ in chronic B hepatitis patients.There was a positive corrlation on CD8~+/CD28~+ and CD40~+、CD40L~+ in chronic B hepatitis patients.There were no remarkable corrlation on CD8~+/CD28~- and CD40~+、CD40L~+ in chronic B hepatitis patients.Conclusion:The costimulation molecules CD40~+、CD40L~+ and CD8~+/CD28~+ are lower,while CD8~+/CD28~- are higher in chronic B hepatitis patients than in the health.To test the expression of CD40~+、CD40L~+ and CD8~+/CD28~+ on peripheral blood of the chronic B hepatitis could help to evaluate patients's celluar immunity and guide clinical treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To test CD40~+、CD40L~+ and CD8~+/CD28~+、CD8~+/CD28~- on peripheral blood of chronic B hepatitis evaluate patients's celluar immunity and to guide clinical treatment.Methods:CD40~+、CD40L~+ and CD8~+/CD28~+、CD8~+/CD28~- expression on peripheral blood cells in chronic B hepatitis were detected by flow cytometry.Results:CD40~+、CD40L~+ and CD8~+/CD28~+ in chronic B hepatitis and liver cirrhosis patients were lower than in the health.CD8~+/CD28~- in chronic B hepatitis and liver cirrhosis patients were higher than in the health.But there were no remarkable difference between in chronic B hepatitis and in liver cirrhosis.Also there were no remarkable difference in mild、moderate、severve chronic B hepatitis and liver cirrhosis (P0.05).There was a positive corrlation on CD40~+ and CD40L~+ in chronic B hepatitis patients.There was a positive corrlation on CD8~+/CD28~+ and CD40~+、CD40L~+ in chronic B hepatitis patients.There were no remarkable corrlation on CD8~+/CD28~- and CD40~+、CD40L~+ in chronic B hepatitis patients.Conclusion:The costimulation molecules CD40~+、CD40L~+ and CD8~+/CD28~+ are lower,while CD8~+/CD28~- are higher in chronic B hepatitis patients than in the health.To test the expression of CD40~+、CD40L~+ and CD8~+/CD28~+ on peripheral blood of the chronic B hepatitis could help to evaluate patients's celluar immunity and guide clinical treatment.
Key concepts: Cirrhosis, Medicine, CD28, CD8, Chronic hepatitis, Hepatitis B, CD40, Immunology